基于GRADE系统的胰高血糖素样肽1受体激动剂治疗2型糖尿病的系统评价的再评价(4)
[ 7 ] LEVIEN DE，BAKER TL . Lixisenatide[J]. Eur J Hosp Pharm，2017，52(1)：65-80.[ 8 ] GRUNBERGER G，CHANG A，GARCIA SG，et al. Mo- notherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with type 2 diabetes：dose-dependent effects on glycaemic control in a randomized，double-blind ......
您现在查看是摘要页，全文长 2792 字符。